Corrigendum to "Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study" [The Lancet Regional Health - Europe 41 (2024) 100912]

Lancet Reg Health Eur. 2024 May 21:42:100940. doi: 10.1016/j.lanepe.2024.100940. eCollection 2024 Jul.

¹ National Cancer Institute, IRCCS Fondazione G.Pascale, Naples, Italy.
² Italian Medicines Agency, Rome, Italy.
³ Department of Oncology, University, Ordine Mauriziano Hospital Umberto I, Turin, Italy.
⁴ Medical Oncology, Hospital, Pescara, Italy.
⁵ Medical Oncology, Comprehensive Cancer Centre, AUSL-IRCCS di Reggio Emilia, Italy.
⁶ Medical Oncology, Civic Hospital Cristina Benfratelli, Palermo, Italy.
⁷ Medical Oncology and Breast Unit, Perrino Hospital, Brindisi, Italy.
⁸ Medical Oncology and Hematology, Civil Hospital, Piacenza, Italy.
⁹ Department of Oncology, University of Turin, AOU Città della Salute e della Scienza di Torino, Turin, Italy.

Abstract

[This corrects the article DOI: 10.1016/j.lanepe.2024.100912.].